Cardinal Health, Inc. (NYSE:CAH) Shares Sold by West Oak Capital LLC

West Oak Capital LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 45.5% during the 4th quarter, Holdings Channel reports. The institutional investor owned 425 shares of the company’s stock after selling 355 shares during the period. West Oak Capital LLC’s holdings in Cardinal Health were worth $50,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of CAH. Graypoint LLC raised its holdings in shares of Cardinal Health by 76.8% in the 4th quarter. Graypoint LLC now owns 4,208 shares of the company’s stock valued at $498,000 after buying an additional 1,828 shares during the period. Birch Capital Management LLC increased its holdings in shares of Cardinal Health by 1.5% in the 4th quarter. Birch Capital Management LLC now owns 28,822 shares of the company’s stock valued at $3,409,000 after acquiring an additional 429 shares during the last quarter. Insight Wealth Strategies LLC raised its position in shares of Cardinal Health by 1.6% during the 4th quarter. Insight Wealth Strategies LLC now owns 19,796 shares of the company’s stock worth $2,341,000 after acquiring an additional 313 shares in the last quarter. CWA Asset Management Group LLC lifted its stake in Cardinal Health by 10.1% during the fourth quarter. CWA Asset Management Group LLC now owns 129,052 shares of the company’s stock worth $15,263,000 after purchasing an additional 11,847 shares during the last quarter. Finally, Pensionfund Sabic boosted its holdings in Cardinal Health by 42.0% in the fourth quarter. Pensionfund Sabic now owns 14,200 shares of the company’s stock valued at $1,679,000 after purchasing an additional 4,200 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.7 %

Shares of Cardinal Health stock traded down $0.83 during trading hours on Friday, hitting $121.70. 1,974,292 shares of the company were exchanged, compared to its average volume of 2,267,382. The business has a 50-day moving average of $119.77 and a 200-day moving average of $110.84. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $126.23. The stock has a market capitalization of $29.45 billion, a price-to-earnings ratio of 23.68, a P/E/G ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. During the same period in the previous year, the company posted $1.73 EPS. Cardinal Health’s revenue was down 4.3% compared to the same quarter last year. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a $0.5056 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.66%. Cardinal Health’s payout ratio is currently 39.30%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Morgan Stanley boosted their price objective on shares of Cardinal Health from $127.00 to $136.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 17th. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $130.00 to $144.00 in a research report on Wednesday. Wells Fargo & Company upgraded shares of Cardinal Health from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $101.00 to $127.00 in a research note on Friday, December 13th. Barclays lifted their target price on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Finally, UBS Group upped their target price on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $133.29.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.